| Financial Year |
March 31 2023 |
| Monetary Funds |
8,551,337,042.05 |
| Held-for-trading Financial Assets |
462,689,994.81 |
| Notes Receivable |
2,104,973,915.51 |
| Accounts Receivable |
16,688,249,781.10 |
| Advances to Suppliers |
1,543,799,406.14 |
| Other Receivables |
542,219,142.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
9,051,437.73 |
| Dividend Receivable |
-- |
| Inventories |
4,959,966,759.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,274,371.30 |
| Other Current Assets |
1,232,094,044.20 |
| Total Current Assets |
38,389,040,108.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
61,094,967.58 |
| Long-term Equity Investment |
1,887,382,817.46 |
| Investment Properties |
53,907,693.33 |
| Fixed Assetes |
8,087,627,127.71 |
| Under-construction Projects |
2,527,496,253.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,050,698,164.79 |
| R&D expenses |
138,004,740.20 |
| Goodwill |
1,020,535,881.41 |
| Long-Term Deferred and Prepaid Expenses |
54,975,052.40 |
| Deferred Income Tax Assets |
804,734,812.79 |
| Other Non-Current Assets |
863,244,857.04 |
| Sub-Total of Non-Current Assets |
18,091,318,289.52 |
| Total Assets |
56,480,358,398.36 |
| Short-Term Loans |
5,666,248,937.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,230,799,865.40 |
| Accounts Payable |
5,456,905,055.83 |
| Accounts Received In Advance |
7,800,672.00 |
| Employee Compensation Payable |
370,686,552.23 |
| Taxes Payable |
414,409,462.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
839,808,317.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,387,642,701.93 |
| Other Current Liabilities |
539,942,611.44 |
| Sub-Total of Current Liabilities |
23,910,403,020.25 |
| Long-term Loans |
6,285,383,282.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,817,224.03 |
| Deferred Income Tax Liabilities |
173,000,498.63 |
| Other Non-Current Liabilities |
98,123,900.00 |
| Sub-Total of Non-Current Liabilities |
6,820,312,243.32 |
| Total Liabilities |
30,730,715,263.57 |
| Paid-In Capital(Or Share Stock) |
2,466,734,657.00 |
| Capital Surplus |
9,278,508,596.45 |
| Surplus Reserve |
624,835,157.38 |
| LESS:Treasury Stock |
311,242,285.66 |
| Undistributed Profits |
11,895,967,731.09 |
| Minority Stockholder's Interest |
1,949,681,114.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,799,962,020.50 |
| Owner's Equity（Stockholder's Equity） |
25,749,643,134.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
56,480,358,398.36 |
